Literature DB >> 34319381

Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.

Jordan E Axelrad1, Adam Faye1,2, James C Slaughter3, Noam Harpaz2,4, Steven H Itzkowitz2, Shailja C Shah5,6.   

Abstract

BACKGROUND: Colorectal strictures have been considered independent risk factors for neoplasia in patients with inflammatory bowel disease (IBD). We examined the association between colorectal stricture and subsequent risk of colorectal neoplasia (CRN) in patients with IBD colitis undergoing colonoscopic surveillance.
METHODS: We conducted a retrospective cohort analysis of patients with IBD colitis enrolled in colonoscopic surveillance for CRN at an academic medical center between 2005 and 2017. Inclusion criteria were IBD involving the colon for ≥8 years (or any duration with primary sclerosing cholangitis [PSC]) undergoing surveillance. Exclusion criteria were advanced CRN (ACRN; colorectal cancer [CRC] or high-grade dysplasia [HGD]) prior to or at enrollment, prior colectomy, or limited (<30%) disease extent or proctitis. Multivariable logistic and Cox regression analysis estimated the association between colorectal stricture on the index colonoscopy and ACRN, CRN (indefinite dysplasia, low-grade dysplasia, HGD, CRC), or colectomy.
RESULTS: Among 789 patients with IBD undergoing CRC surveillance, 72 (9%; 70 with Crohn's colitis) had a colorectal stricture on index colonoscopy. There was no significant difference in the frequency of ACRN or requirement for colectomy between patients with vs without a colorectal stricture (P > .05). Colorectal stricture was not associated with subsequent ACRN (adjusted odds ratio [aOR], 1.41; 95% CI, 0.49-4.07), CRN (aOR, 1.15; 95% CI, 0.51-2.58), or colectomy (aOR, 1.10; 95% CI, 0.65-1.84).
CONCLUSIONS: In this analysis of patients with IBD colitis undergoing CRN surveillance, the presence of a colorectal stricture was not independently associated with risk of ACRN or colectomy. Multicenter, prospective studies are needed to confirm these findings, particularly in patients with ulcerative colitis-associated colorectal stricture.
© 2021 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; colorectal cancer; dysplasia; stricture; ulcerative colitis

Mesh:

Year:  2022        PMID: 34319381      PMCID: PMC9165549          DOI: 10.1093/ibd/izab177

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   7.290


  26 in total

Review 1.  Cancers complicating inflammatory bowel disease.

Authors:  Laurent Beaugerie; Steven H Itzkowitz
Journal:  N Engl J Med       Date:  2015-04-09       Impact factor: 91.245

2.  Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee.

Authors:  Asher Kornbluth; David B Sachar
Journal:  Am J Gastroenterol       Date:  2010-01-12       Impact factor: 10.864

3.  Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic Strictures.

Authors:  Mathurin Fumery; Guillaume Pineton de Chambrun; Carmen Stefanescu; Anthony Buisson; Aude Bressenot; Laurent Beaugerie; Aurelien Amiot; Romain Altwegg; Guillaume Savoye; Vered Abitbol; Guillaume Bouguen; Marion Simon; Jean-Pierre Duffas; Xavier Hébuterne; Stéphane Nancey; Xavier Roblin; Emmanuelle Leteurtre; Gilles Bommelaer; Jeremie H Lefevre; Francesco Brunetti; Françoise Guillon; Yoram Bouhnik; Laurent Peyrin-Biroulet
Journal:  Clin Gastroenterol Hepatol       Date:  2015-05-19       Impact factor: 11.382

4.  Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study.

Authors:  Ola Olén; Rune Erichsen; Michael C Sachs; Lars Pedersen; Jonas Halfvarson; Johan Askling; Anders Ekbom; Henrik Toft Sørensen; Jonas F Ludvigsson
Journal:  Lancet       Date:  2020-01-11       Impact factor: 79.321

5.  Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis.

Authors:  Anouk M Wijnands; Michiel E de Jong; Maurice W M D Lutgens; Frank Hoentjen; Sjoerd G Elias; Bas Oldenburg
Journal:  Gastroenterology       Date:  2020-12-29       Impact factor: 22.682

6.  Local complications of ulcerative colitis: stricture, pseudopolyposis, and carcinoma of colon and rectum.

Authors:  F T De Dombal; J M Watts; G Watkinson; J C Goligher
Journal:  Br Med J       Date:  1966-06-11

Review 7.  Intestinal inflammation and cancer.

Authors:  Thomas A Ullman; Steven H Itzkowitz
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

8.  Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.

Authors:  Ola Olén; Rune Erichsen; Michael C Sachs; Lars Pedersen; Jonas Halfvarson; Johan Askling; Anders Ekbom; Henrik Toft Sørensen; Jonas F Ludvigsson
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-02-14

9.  Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease.

Authors:  Sverre Söderlund; Lena Brandt; Annika Lapidus; Per Karlén; Olle Broström; Robert Löfberg; Anders Ekbom; Johan Askling
Journal:  Gastroenterology       Date:  2009-05       Impact factor: 22.682

10.  No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases.

Authors:  Remi Mahmoud; Shailja C Shah; Joren R Ten Hove; Joana Torres; Erik Mooiweer; Daniel Castaneda; Jason Glass; Jordan Elman; Akash Kumar; Jordan Axelrad; Thomas Ullman; Jean-Frederic Colombel; Bas Oldenburg; Steven H Itzkowitz
Journal:  Gastroenterology       Date:  2018-12-07       Impact factor: 22.682

View more
  2 in total

Review 1.  Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management.

Authors:  Shailja C Shah; Steven H Itzkowitz
Journal:  Gastroenterology       Date:  2021-10-29       Impact factor: 22.682

Review 2.  Colorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention.

Authors:  Wenqian Li; Tiantian Zhao; Dacheng Wu; Jiajia Li; Mei Wang; Yunyun Sun; Sicong Hou
Journal:  Curr Oncol       Date:  2022-08-25       Impact factor: 3.109

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.